Fecal microbiota transplant increases survival in metastatic colorectal cancer treatment
In a recent study published in e-clinical medicineresearchers are evaluating the use of fecal microbiota transplantation to increase the efficacy of anti-programmed cell death protein 1 (PD-1) therapy for patients with microsatellite-stable metastatic colorectal cancer. study: Fecal microbiota transplantation with tislelizumab and fruquintinib in refractory microsatellite-stable metastatic colorectal cancer: an open-label, single-arm, phase II study […]
Diagnose IBS and target gut microbiota and metabolites to improve symptoms
The educational content in this post was created in collaboration with Bromatech and independently developed and approved by the GMFH publishing team and editorial board. Diagnosed with IBS The use of symptom-based criteria for the diagnosis of gastrointestinal dysfunction may help physicians diagnose and justify such disorders, rather than seeing them solely as a combination […]